Prepared for Enhance Business Consulting Inc. · revised 2026-08-27
Teaming and subcontract assessment. Independently re-verified claim by claim; corrections applied. Every hard number carries a source, inference is marked.
Prepared: 2026-08-27 · Revised after independent verification — see DOSSIER-VERDICT.md
Purpose: Teaming / subcontract approach assessment
Classification: Open-source business intelligence, prepared for a teaming decision. Every hard number carries a source. Inference is marked inference.
Accel Solutions is a home-based, single-principal federal advisory committee (FACA) support specialist that built $14.7M of lifetime federal revenue on sole-source awards — 42.5% explicitly coded 8(a) sole source, 64.7% counting the FAR 6.302-5(a)(2)(i) statutory hook — and whose 8(a) participation expired 2025-03-13. ⚠️ The remaining 34.8% ($5,118,174.84) came via FAR 6.302-1(b)(1) "unique source," which does not depend on 8(a) status and therefore survived graduation.
Four facts dominate any teaming decision:
Read for a teaming approach: Accel is not a prime to shelter under — it is a firm that just lost its sole-source engine and has no demonstrated competitive capture capability. But it holds a genuinely rare and portable niche credential (FACA/advisory-committee management across four agencies) and a fresh WOSB/EDWOSB certification (2026-03-10). The realistic play is a peer teaming arrangement into competitive small-business set-asides, where each side supplies what the other lacks — not a subcontract flow-down from a healthy prime. See §9.
| Field | Value | Source |
|---|---|---|
| Legal name | ACCEL SOLUTIONS, LLC | VA SCC entity S4075596 |
| VA SCC Entity ID | S4075596 | VA SCC CIS |
| Formation date | 2012-05-15 | VA SCC CIS |
| Entity status | Active (status date 2020-07-28) | VA SCC CIS |
| Entity type | Limited Liability Company, perpetual duration | VA SCC CIS |
| Address | 6401 Caleb Ct, Alexandria, VA 22315-3732 | VA SCC / SAM / SBA |
| Jurisdiction | Virginia, Fairfax County, VA-08 | VA SCC / USAspending |
| CAGE code | 6RNF9 | SBA SBS profile |
| Current UEI | H18BTKJP1VA5 | SBA SBS profile, SAM status Active |
| Legacy UEI | MSCVXFDMNMB9 (DUNS 078481208) | USAspending recipient record |
Both UEIs resolve to the same single legal entity — the Virginia SCC returns exactly one "ACCEL SOLUTIONS" record, so there is no second company.
The two ran concurrently for four fiscal years (FY2022–FY2025), which is not normal and caused a real contract-administration problem. FDA contract 75F40121P00502 carries two modifications explicitly fixing it:
P00004 (signed 2023-03-06): "THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE UEI INFORMATION THAT WAS PREVIOUSLY INCORRECT AND BEING SENT TO THE WRONG BANK. THE UEI NUMBER IS NOW H18BTKJP1VA5." P00005 (2023-07-05): same language, with $345,024.00 obligated
Determination: H18BTKJP1VA5 is the current UEI. Evidence: it is the UEI on the SBA certification profile (SAM registration status Active, profile last updated 2026-02-01); it is the UEI on both post-2022 awards; and MSCVXFDMNMB9 returns 0 results in SBA's registry (positive control passed — see §4).
inference The likely trigger for the second registration is the 2021-04-13 sale of 6401 Caleb Ct (§3) combined with the government-wide DUNS→UEI transition of April 2022 — an address change plus a system migration, producing a duplicate rather than an update. This is unconfirmed.
⚠️ Practical warning for any teaming paperwork: confirm which UEI the counterparty intends to contract under before signing anything. This entity has a documented history of UEI errors severe enough to require bilateral contract modifications.
Principal: KIMBERLY FRIERSON — verified across three independent sources.
| Source | What it establishes |
|---|---|
| Virginia SCC (authoritative) | Registered Agent, RA Type "Individual", RA Qualification: "Member or Manager of the Limited Liability Company" — this is ownership/control-level standing, not a hired agent service |
| SBA Small Business Search (authoritative) | Listed Contact Person for the certified entity |
| LinkedIn / Crunchbase | Title given as Chief Executive Officer, Accel Solutions LLC |
The Virginia SCC record is the strongest evidence: Virginia requires an RA who qualifies under a specific statutory category, and "Member or Manager of the LLC" is a legal attestation of membership in the LLC.
Background: not independently verified; omitted rather than repeat aggregator claims.
Note on the email address: SBA lists the contact mailbox as kwilson@accelsolutionsllc.com. It does not match the principal's surname; treat it as the registered business contact, and do not assume a second person exists.
Other principals: none identified. SBA's "Current Principals" field reads "Not Provided." The company website's About Us page names no leadership at all — no founder, no executives, no team. USAspending's executive-compensation block returns five null officers. inference This is consistent with a very small firm, likely owner-plus-contract-staff.
EDWOSB confirmation: The EDWOSB certification requires a woman owner who is both economically disadvantaged and holds ≥51% ownership with control. SBA granted EDWOSB on 2026-03-10, which means SBA affirmatively vetted Frierson's majority ownership and control as of that date. This is the single most reliable ownership fact in the dossier.
6401 Caleb Ct is a single-family residence, not commercial space. The firm has no separate office.
It is simultaneously the registered office, the principal office, the SAM business address, and — critically — the place of performance on the active HITAC contract (Alexandria VA 22315-3732). Remote performance is explicitly authorized on the FDA contract:
75F40121P00502 P00006 (2023-11-03): "THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE PLACE OF PERFORMANCE TO ALLOW THE CONTRACTOR TO WORK RE[MOTELY]"
By contrast, the FDA CDER contract's place of performance was Silver Spring, MD 20993 — the FDA White Oak campus — i.e. that work was performed on-site at the customer.
Queried against SBA's authoritative public certification registry at search.certifications.sba.gov:
Positive control run first. UEI FTHSR55SMJD4 → exactly 1 result, ENHANCE BUSINESS CONSULTING INC. (VOSB/SDVOSB, contact Robert Knuckles Jr). Control passed, so the searches below are trustworthy.
Target result (UEI H18BTKJP1VA5, fresh navigation to root before query):
ACCEL SOLUTIONS, LLC
Current SBA certifications: WOSB EDWOSB
Previous SBA certifications: 8(a)
From the full SBA profile record (/profile/H18BTKJP1VA5/6RNF9, read 2026-08-27 10:13 AM EDT):
| Certification | Status | Entrance | Exit |
|---|---|---|---|
| 8(a) Business Development Program | Previously certified | 2015-03-13 | 2025-03-13 |
| Women-Owned Small Business (WOSB) | Certified | 2026-03-10 | 2029-03-10 |
| Economically-Disadvantaged WOSB (EDWOSB) | Certified | 2026-03-10 | 2029-03-10 |
SBA Servicing Office: Washington Metropolitan Area District Office (office code 0353).
The 8(a) term ran exactly 10 years, not the statutory 9. inference This is almost certainly the one-year COVID extension SBA offered program participants under Section 8 of the Consolidated Appropriations Act, 2021, which let participants elect to extend their program term by 12 months. A 2015 entrant electing that extension exits in 2025. Nothing here suggests early termination or adverse action — this reads as normal graduation by term completion.
Accel did not merely lose a marketing label. 8(a) sole-source authority produced 42.5% of lifetime revenue explicitly, and 64.7% including the FAR 6.302-5(a)(2)(i) hook (§7). But 34.8% arrived under FAR 6.302-1(b)(1) "unique source" — an authority independent of 8(a) that they still hold. With the 8(a) expired:
inference That gap is consistent with a firm that did not plan its graduation transition in advance.Three sources still assert an active 8(a) that SBA says ended:
Do not treat this as fraud. Stale SAM records are extremely common and the website copy is likely simple neglect. But do treat the SBA registry as controlling, and note that a firm which has not updated its own capability claims in 17 months is telling you something about its business-development intensity.
Critical This section materially corrects the working figures. A profile built on UEI H18BTKJP1VA5 alone captures $4,956,131 — only 34% of the company's federal history. Adding legacy UEI MSCVXFDMNMB9 brings the true lifetime total to $14,693,955.46.
| FY | MSCVXFDMNMB9 | H18BTKJP1VA5 | Combined |
|---|---|---|---|
| 2015 | 401,776.00 | — | 401,776.00 |
| 2016 | 84,640.00 | — | 84,640.00 |
| 2017 | 1,188,452.84 | — | 1,188,452.84 |
| 2018 | 1,617,012.12 | — | 1,617,012.12 |
| 2019 | 1,541,221.60 | — | 1,541,221.60 |
| 2020 | 1,139,728.33 | — | 1,139,728.33 |
| 2021 | 1,480,947.03 | — | 1,480,947.03 |
| 2022 | 947,375.93 | 1,613,005.70 | 2,560,381.63 |
| 2023 | 1,034,866.29 | 1,598,775.50 | 2,633,641.79 ← peak |
| 2024 | 497,625.60 | 708,082.69 | 1,205,708.29 |
| 2025 | −195,821.34 | 729,286.98 | 533,465.64 |
| 2026 | — | 306,980.19 | 306,980.19 |
| TOTAL | 9,737,824.40 | 4,956,131.06 | 14,693,955.46 |
Source: USAspending spending_over_time, filtered by recipient_id, FY2008–FY2026, pulled 2026-08-27.
| Federal account | Amount | Share |
|---|---|---|
| 075-0130 — Office of the National Coordinator for Health IT (ONC) | $7,851,190.59 | 53.4% |
| 075-0600 — Salaries & Expenses, FDA | $5,980,516.78 | 40.7% |
| 012-1400 — Salaries & Expenses, USDA Agricultural Research Service | $747,923.85 | 5.1% |
| 069-0102 / 069-8350 / 069-8159 — DOT (OST, FTA, FMCSA) | $114,324.24 | 0.8% |
Critical Correction to the working brief: ONC is 53%, not ~100%. FDA is 41%. Restricting to the current UEI alone would have shown ONC at just 35% (with FDA at 65%). Neither single-UEI view is representative. The company is roughly two-thirds HHS-diversified between ONC and FDA, with a real but small non-HHS tail at USDA and DOT.
⚠️ Reconciliation gate. The awards below total $14,693,955.46, matching §5 exactly. An earlier revision of this section listed only eleven awards totalling $11,571,812.62 and left $3,122,142.84 (21.2%) of lifetime revenue unaccounted for — the omission below. Any future edit to this section must re-sum against §5; an unexplained gap means the query is unfinished, not that the money is missing.
| Field | Value |
|---|---|
| Recipient UEI | MSCVXFDMNMB9 (legacy) |
| Awarding office | HHS / Office of the Assistant Secretary for Administration (ASA) |
| Type | IDV_B_A — Indefinite Delivery / Requirements |
| Obligated | $3,122,142.84 |
| Period of performance | 2017-05-04 → 2020-08-31 |
| NAICS / PSC | 561110 / R699 |
| Set-aside | NO SET ASIDE USED |
| Competition | NOT COMPETED — 1 offer · FAR 6.302-1(b)(1) UNIQUE SOURCE |
| Work | mod P00005: "FEDERAL ADVISORY COMMITTEE SUPPORT SERVICES" |
Why it was missed: the first sweep queried only award_type_codes A/B/C/D and never touched
the IDV families, so the parent vehicle never surfaced. Why it matters twice over: it is the
single largest award in the portfolio, and it was not an 8(a) action — it is one of the two
FAR 6.302-1(b)(1) unique-source awards that survive 8(a) graduation (§4). It also received
exactly one offer, so the single-offer finding strengthens to 12 of 12.
| Field | Value |
|---|---|
| Description | ONC HEALTH INFORMATION TECHNOLOGY ADVISORY COMMITTEE (HITAC) TECHNICAL SUPPORT SERVICES |
| Awarding office | HHS / ASFR — OMAS Strategic Buying Center (HHS Mission) |
| Signed / start | 2024-08-22 / 2024-09-02 |
| Current PoP end | 2027-09-01 |
| Potential end | 2029-09-01 (two further option years exist) |
| Obligated to date | $1,744,389.13 (outlays $928,449.96) |
| Set-aside | 8(A) SOLE SOURCE (FAR 6.302-5(a)(2)(i)) |
| Competition | NOT AVAILABLE FOR COMPETITION — 1 offer |
| Pricing | Time & Materials |
| NAICS / PSC | 541611 / R799 |
| Place of performance | Alexandria VA 22315-3732 — the owner's home |
Transaction history — this is the most revealing record in the dossier:
| Date | Mod | Obligated | Action |
|---|---|---|---|
| 2024-08-22 | 0 | $708,082.69 | Base period award |
| 2025-08-08 | P00001 | $729,326.25 | Exercise Option Period 1 (2025-09-02→2026-09-01); COR Lihua Zeng → Dustin Charles |
| 2025-12-10 | P00002 | $0.00 | COR Dustin Charles → back to Lihua Zeng |
| 2026-03-27 | P00003 | $0.00 | "BILATERAL MODIFICATION … TO REDUCE THE SCOPE" |
| 2026-04-24 | P00004 | $306,980.19 | Exercise Option Period 2 |
Interpretation. This contract is being deliberately shrunk, not merely underfunded. A bilateral scope-reduction mod in March 2026 was followed one month later by an Option Period 2 exercise at $306,980 versus Option Period 1's $729,326 — a 58% cut. Option Period 2 runs 2026-09-02 → 2027-09-01, so the descoped year begins in 6 days. The government is keeping Accel on contract at roughly 42% of prior scale.
The two COR reversals inside four months (P00001, P00002) suggest program-office churn on the customer side — consistent with the 2025 HHS restructuring that reorganized ONC into ASTP. inference
| Field | Value |
|---|---|
| Awarding office | HHS / FDA |
| PoP | 2021-08-31 → 2026-09-11 |
| Potential end | 2026-09-11 — identical to PoP end, so NO option years remain |
| Obligated | $1,996,032.00 |
| Set-aside | NO SET ASIDE USED |
| Competition | NOT COMPETED — 1 offer |
| Last action | P00009, 2025-06-24, $500,486.40 — "ACCEL EXPORT CERTIFICATION PROGRAM SUPPORT" |
⏰ This contract expires in 15 days (2026-09-11) and has no options left. Absent a new award, a follow-on, or a bridge, roughly $500K/year of run-rate revenue — the majority of what remains — stops. Whether a recompete or follow-on exists is NOT DETERMINED (see §11).
| PIID | Customer | PoP | Obligated | Vehicle |
|---|---|---|---|---|
| 75F40122C00164 | FDA / CDER — Office of Computational Science | 2022-09-12 → 2024-09-25 | $3,211,741.93 | FAR 6.302-5(a)(2)(i); "NO SET ASIDE" coded |
| 75P00120C00050 | HHS / ASA — Federal Advisory Committee Support Services | 2020-09-01 → 2024-08-31 | $2,984,658.62 | 8(a) sole source |
Both ended within a month of each other in September 2024 — that concurrence is the mechanical cause of the FY2024→FY2026 revenue collapse.
The ONC FACA contract (75P00120C00050) took a −$696,307.74 deobligation on 2025-08-06, nearly a year after expiry — about 18.9% of its face value returned unspent.
The FDA CDER contract description names the COR: Divine Agbale, divine.agbale@fda.hhs.gov. Note: several third-party aggregators (GovConInABox among them) mis-scrape this FDA official as Accel's own point of contact. He is the government's COR, not Accel personnel. Do not contact him as a route to the company.
| PIID | Customer | PoP | Obligated | Work |
|---|---|---|---|---|
| 75F40118P20361 | FDA | 2018-09-11 → 2021-09-11 | $772,742.85 | Export certificates support (8(a) sole source) |
| AG32SBC150020 | USDA ARS | 2015-09-30 → 2017-09-29 | $485,250.25 | Project manager services, technical project leadership |
| AG32SCC170001 | USDA ARS | 2016-12-12 → 2017-12-12 | $172,452.40 | Database administration & programming |
| 1232SC18P0055 | USDA ARS | 2018-01-24 → 2019-01-23 | $90,221.20 | Database administration support |
| 693JK419F960011 | DOT / OST | 2019-04-17 → 2020-04-16 | $43,916.61 | FACA meeting support, call order under BPA 693JK418A600022 |
| 69319519F200009 | DOT / FTA | 2019-02-27 → 2020-02-26 | $37,476.58 | Transit Advisory Committee for Safety (TRACS) program support |
| 693JJ419F000022 | DOT / FMCSA | 2019-06-12 → 2020-05-28 | $32,931.05 | Motor Carrier Safety Advisory Committee (MCSAC) + Medical Review Board |
The three DOT awards ran as call orders under a DOT-wide BPA, 693JK418A600022 — evidence the firm once held a multi-agency ordering vehicle.
| PIID | Amount | Set-aside | Competition | Offers |
|---|---|---|---|---|
| 75F40122C00164 | $3,211,742 | No set aside | Not available for competition | 1 |
| 75P00120C00050 | $2,984,659 | 8(a) sole source | Not available for competition | 1 |
| 75F40121P00502 | $1,996,032 | No set aside | Not competed | 1 |
| 75P00124C00019 | $1,744,389 | 8(a) sole source | Not available for competition | 1 |
| 75F40118P20361 | $772,743 | 8(a) sole source | Not available for competition | 1 |
| AG32SBC150020 | $485,250 | 8(a) sole source | Not available for competition | 1 |
| AG32SCC170001 | $172,452 | 8(a) sole source | Not available for competition | 1 |
| 1232SC18P0055 | $90,221 | 8(a) sole source | Not available for competition | 1 |
| 693JK419F960011 | $43,917 | No set aside | Not competed under SAP | 1 |
| 69319519F200009 | $37,477 | No set aside | Competed under SAP | 1 |
| 693JJ419F000022 | $32,931 | No set aside | Not competed under SAP | 1 |
Every award in company history received exactly one offer. The single award marked "competed" is a $37,477 simplified-acquisition action that still drew one bid.
Accel has no demonstrated record of winning a contested competition. For a firm that has just lost sole-source eligibility, this is the most important risk fact in the dossier.
Note the coding contradiction on 75F40122C00164 ($3.2M, the largest award): type_set_aside reads "NO SET ASIDE USED" while the justification is FAR 6.302-5(a)(2)(i) "AUTHORIZED BY STATUTE." That FAR citation is the statutory hook for 15 U.S.C. 637(a) — the 8(a) program. inference This is an 8(a) award with an inconsistent set-aside field, a common FPDS coding error. Flagged rather than silently resolved.
The briefing question was "is a recompete coming?" It already came, in August 2025, and Accel did not win it as prime.
Prime award 140D0425F0766 — CHICKASAW HEALTH CONSULTING, LLC (UEI PK29BHT5S9C5)
| Field | Value |
|---|---|
| Description | "HEALTH AND HUMAN SERVICES, ASSISTANT SECRETARY FOR TECHNOLOGY POLICY / OFFICE OF THE NATIONAL [COORDINATOR] FOR HEALTH INFORMATION TECHNOLOGY SUPPORT RECOMPETE" |
| Awarding office | DOI — Interior Business Center, Acquisition Services Directorate (assisted acquisition) |
| Funding agency | HHS / ASA — Program Support Center |
| Signed / start | 2025-08-27 / 2025-08-31 |
| PoP | 2025-08-31 → 2027-08-30 (potential end 2030-08-30) |
| Obligated | $8,445,323.61 |
| Set-aside | SMALL BUSINESS SET ASIDE — TOTAL |
| Competition | FULL AND OPEN COMPETITION |
| NAICS / PSC | 541611 / DA01 |
| Ordering vehicle | GSA schedule 47QTCA20D00BR |
| Place of performance | Washington, DC 20201 (HHS HQ) |
What happened, in sequence:
The pattern is unambiguous. Once Accel could no longer be handed the work sole-source, the requirement went competitive and a larger, more capture-capable firm took it. Accel was retained as a small sub — plausibly to preserve continuity of the specific HITAC institutional knowledge. inference
| Field | Value |
|---|---|
| Sub-award ID | 782-01930-0000-02 |
| Date | 2025-09-24 |
| Amount | $182,765.44 |
| Prime | CHICKASAW HEALTH CONSULTING, LLC (PK29BHT5S9C5) |
| Prime award | 140D0425F0766 |
Scope (verbatim excerpt): "expert consulting on strategic planning, project management, and creating high level briefing materials for the COO … maintaining list of priority projects outlined by OCOO … tracking milestones and progress for strategic projects … meeting with OCOO division directors, deputies and branch chiefs to identify risks … Microsoft Office Suite, Salesforce, SharePoint, MS Teams, and Tableau."
This is a single, recent, one-off subaward — not a recurring relationship. A search of all USAspending subaward records for "ACCEL SOLUTIONS" returns exactly one result. As of 2026-08-27 there is no evidence of a second Chickasaw subaward, and the arrangement is ~11 months old.
Chickasaw Health Consulting scale (prime obligations by FY, UEI PK29BHT5S9C5):
| FY | Amount | FY | Amount | |
|---|---|---|---|---|
| 2017 | $4,586,094 | 2022 | $58,373,799 ← peak | |
| 2018 | $12,127,237 | 2023 | $29,238,765 | |
| 2019 | $19,710,491 | 2024 | $14,984,404 | |
| 2020 | $16,640,051 | 2025 | $7,504,715 | |
| 2021 | $47,478,105 | 2026 | $3,868,188 | |
| TOTAL | $214,511,848 |
⚠️ Chickasaw is declining too — and faster in absolute terms. From a $58.4M peak in FY2022 to $3.9M in FY2026, a 93% fall. Chickasaw Health Consulting sits in the Chickasaw Nation Industries (CNI) tribal 8(a) family, whose entities enjoy no 9-year term limit and unlimited-ceiling sole-source authority — a structural advantage Accel has permanently lost. But the specific CHC entity is not currently a growth platform.
Assessment: the Chickasaw relationship is real but immature and small ($182,765). It is a lead, not a moat. It is also the single most useful thing Accel currently possesses, because it is their live connection to the vehicle that now owns their former customer.
The public marketing ("management consulting, information technology, and professional staff augmentation") is generic and unhelpful. The contract record shows something much sharper.
This is the through-line across four agencies and eleven years (12 obligating prime awards; §6 reconciles to §5's $14,693,955.46 exactly):
FACA support is a genuine, narrow, portable specialty. Running a chartered federal advisory committee means managing charters and renewals, member nomination and vetting, Federal Register notices, public-meeting logistics, transcripts and minutes, conflict-of-interest screening, and recommendation tracking. Nearly every cabinet department runs advisory committees, and few small firms specialize in this. This is Accel's most valuable and most transferable asset — considerably more so than the "management consulting" label suggests.
Database administration, programming, and project management, 2015–2019 (~$748K). No activity in seven years.
POST search.certifications.sba.gov/_api/v2/search: naics_primary = 541611, with nine codes on file — 541420, 541430, 541512, 541519, 541611, 541612, 541618, 541690, 541990. No construction code appears. Their SBA NAICS profile is accurate and they will surface correctly in a contracting officer's capability search.inference Taken together, this is a firm whose business-development apparatus is essentially inactive. That is a risk — and simultaneously the opening described below.
| Asset | Strength |
|---|---|
| FACA/advisory-committee specialization | Strong. Rare, narrow, credential-like, portable across departments. Past performance at HHS, DOT, FTA, FMCSA. |
| FDA regulatory operations past performance | Strong. Eight years continuous, two program areas, including on-site CDER technical work. |
| Incumbency at HITAC | Moderate and eroding. Runs to 2027-09-01 with options to 2029. Ceiling cut 36.5% by mod P00003 (2026-03-27, −$1,373,070.94 → $2,386,251.81); option-year funding fell 58%. Two distinct figures — keep them apart. |
| WOSB / EDWOSB certification | Moderate. Freshly SBA-certified 2026-03-10 — real, vetted, and usable for competitive set-asides. |
| Chickasaw sub relationship | Weak but live. One subaward, $182,765, ~11 months old. |
| Prime past performance depth | Moderate. $14.7M lifetime across 11 contracts and 4 agencies is a credible CPARS record. |
| Gap | Severity |
|---|---|
| Any competitive win, ever (11/11 single-offer) | Critical Critical |
| 8(a) sole-source authority (expired 2025-03-13) | Critical Critical |
| Revenue trajectory (−88% from peak) | Critical |
| Near-term contract cliff (FDA expires 2026-09-11) | Critical |
| Capture/BD infrastructure (no capability statement, wrong NAICS, stale website) | Significant Significant |
| Bench depth (no named staff; single principal) | Significant Significant |
| Bonding, facility clearance, quality standards | Unknown Unknown — all "Not Provided" |
Do not approach Accel as a prime to subcontract under. Their prime pipeline is one descoped contract and one expiring contract. Flow-down work from them is unlikely to materialize at meaningful scale.
Approach them as a complementary teaming partner for competitive small-business set-asides. The logic:
Lead with capture capability, not with a request for work. The credible pitch is: "You have FACA past performance almost nobody else has. You now have to win competitively. We do that. Let's team on the next ONC/ASTP or FACA-adjacent set-aside — and here is specifically how we'd split it."
Concrete near-term targets to raise: - The FDA export certificate follow-on (75F40121P00502 expires 2026-09-11) — if it recompetes, they are the incumbent with eight years of program knowledge and no capture arm. - HITAC option years 3 and 4 (2027-09-01 → 2029-09-01) — exercisable but not guaranteed, and the descoping trend argues for reinforcement. - FACA support requirements at other departments — their DOT/FTA/FMCSA past performance is dormant and reusable. - Chickasaw prime 140D0425F0766 — runs to 2030-08-30; growing their sub position there is the lowest-friction expansion available.
not run A CourtListener / PACER litigation check was not performed in this pass — recommend before signing. The repo's scripts/osint/courtlistener_search.py covers this.All contact details below are verified from primary sources. No name, title, address, or contact detail in this dossier is invented.
| Channel | Value | Source |
|---|---|---|
| Principal | KIMBERLY FRIERSON — Member/Manager (VA SCC); CEO (LinkedIn/Crunchbase) | VA SCC S4075596; SBA SBS |
| Direct email | kwilson@accelsolutionsllc.com | SBA SBS profile (listed contact person's email) |
| Phone | 703-801-5421 | SBA SBS profile and company website — two independent sources agree |
| General email | info@accelsolutionsllc.com | accelsolutionsllc.com |
| Website | https://accelsolutionsllc.com | SBA SBS profile |
| LinkedIn (company) | https://www.linkedin.com/company/accel-solutions-llc | Web search |
| LinkedIn (principal) | https://www.linkedin.com/in/kimberly-frierson-5b339647/ | Web search result title: "Kimberly Frierson - Chief Executive Officer, Accel Solutions LLC" — URL not independently loaded; see §11 |
| Mailing / registered office | 6401 Caleb Ct, Alexandria, VA 22315-3732 | VA SCC; SAM; SBA |
| Registered agent | Kimberly Frierson (individual), Fairfax County | VA SCC |
Recommended route: direct email to kwilson@accelsolutionsllc.com, referencing the HITAC/FACA past performance specifically. This address is the SBA-registered contact for the certified entity, which makes it the most reliable channel. The phone number is corroborated by two independent sources.
Do NOT contact: Divine Agbale (divine.agbale@fda.hhs.gov). Despite several commercial aggregators listing him as Accel's point of contact, he is the FDA's Contracting Officer Representative on an expired government contract. Contacting him would be both useless and unprofessional.
Address handling: 6401 Caleb Ct is the owner's private residence. Treat it as a mailing address of record. Do not door-knock or send couriers requiring signature.
Recorded rather than silently resolved, per collection discipline.
8(a) status — three sources disagree with SBA. SAM self-attestation, the company website, and every commercial aggregator say "8(a) certified." SBA's registry says exit 2025-03-13. SBA controls; the others are stale or derived from the stale SAM record.
ONC concentration. Working brief said ~100% ONC. Actual: 53.4% ONC / 40.7% FDA across both UEIs. Current-UEI-only view shows 35% ONC / 65% FDA. The 100% figure is not reproducible under any filter I ran.
Lifetime total. $4,956,131 (current UEI) vs $14,693,955 (both UEIs). Both are correct for their scope; only the combined figure describes the company.
Set-aside coding on 75F40122C00164. type_set_aside = "NO SET ASIDE USED" while justification = FAR 6.302-5(a)(2)(i) "authorized by statute," the 8(a) hook. inference FPDS coding error; treated as an 8(a) award.
Contract pricing vs description on 75F40122C00164. Description says "LABOR HOUR AWARD"; type_of_contract_pricing is coded J. Noted; low stakes; not resolved.
GovConInABox totals. Reports "$4.65M across 7 awards" and names the FDA COR as Accel's POC. Both are wrong against primary USAspending data. Aggregator not reliable here.
~~UEI on the FDA export contract — direction of the correction is ambiguous.~~ RESOLVED and withdrawn. The full modification text names the destination explicitly: "…PREVIOUSLY INCORRECT AND BEING SENT TO THE WRONG BANK. THE UEI NUMBER IS NOW H18BTKJP1VA5." The earlier quote was truncated before that sentence. Payments going to the wrong bank account is the more serious fact and is now carried in §2.
Positive-control UEI string. The working brief gave FTHSR55SMJD4; an open browser tab showed FTH5R55SMJD4. The brief's string is correct — FTHSR55SMJD4 returned exactly 1 result (Enhance Business Consulting Inc.), matching the stated expectation.
location.href navigations to /feed/; the profile was never loaded. Frierson's CEO title rests on the search-result page title plus Crunchbase, corroborated by SBA (contact person) and VA SCC (member/manager). Treat the title "CEO" as well-supported and the biographical details (aggregator biography) as unverified.spending_by_award silently ignores recipient_id, returning unrelated awards. Use recipient_search_text: ["<UEI>"] instead — that filter is respected and was used for all award-level results here. spending_over_time and spending_by_category/* do honor recipient_id.spending_by_award requires filters.award_type_codes; subaward queries require it too.https://search.certifications.sba.gov/ fresh, set #search-input via the native value setter plus an input event, then click the "Quick Search" button (Enter does not submit).txtEntityName field on /Account/Login and click #btnLoginEntitySearch — no login required. Entity detail opens via the JS call SeriesLLC(<businessId>,'Limited Liability Company','False').Primary / authoritative
- U.S. SBA Small Business Search — certification registry: https://search.certifications.sba.gov/profile/H18BTKJP1VA5/6RNF9 (read 2026-08-27, 10:13 AM EDT)
- Virginia State Corporation Commission, Clerk's Information System — entity S4075596 / businessId 654403
- USAspending.gov API v2 — recipient profiles, spending_over_time, spending_by_category/*, spending_by_award, /awards/<id>/, /transactions/ (all pulled 2026-08-27)
- USAspending recipient page: https://www.usaspending.gov/recipient/a8a43593-840c-c870-6522-4f3ec670a5c0-P/latest
Company-published - https://accelsolutionsllc.com/about-us/
Secondary (used only where noted, treated as low confidence) - LinkedIn search-result metadata; Crunchbase person/company profiles - GovConInABox contractor profile — found unreliable; see §11.6 - Zillow / Trulia / Redfin — confirmed 6401 Caleb Ct is residential, not commercial
Compiled 2026-08-27. All obligation figures are USAspending prime-award obligations pulled the same day and will drift with subsequent modifications.